Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants
Semin Thromb Hemost
.
1992;18(2):200-17.
doi: 10.1055/s-2007-1002426.
Authors
J Hauptmann
1
,
F Markwardt
Affiliation
1
Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Germany.
PMID:
1631568
DOI:
10.1055/s-2007-1002426
No abstract available
Publication types
Review
MeSH terms
Animals
Anticoagulants / pharmacology*
Drug Design
Fibrinolytic Agents / pharmacology
Humans
Thrombin / antagonists & inhibitors*
Substances
Anticoagulants
Fibrinolytic Agents
Thrombin